Status:

COMPLETED

Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborating Sponsors:

Brigham and Women's Hospital

Conditions:

Malignant Tumors

Subcutaneous Tumors

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate whether this new method of taking pictures called Dynamic Area Telethermometry (DAT) might be a good way of looking at patients with cancer that is relatively ...

Detailed Description

* The DAT system resembles a video camera which picks up changes in body temperature which may reflect disease-related changes in blood flow to some areas, particularly those involved with tumors. * P...

Eligibility Criteria

Inclusion

  • Histologically confirmed malignancy
  • Primary or secondary tumor location amendable to DAT scanning: subcutaneous tissues
  • Older than 15 years of age
  • Able to withhold movement for 20 seconds, hold breath for 20 seconds for chest wall lesions and clinically stable acutely

Exclusion

  • Uncontrolled motion
  • Tumors not verified or measurable by standard imaging

Key Trial Info

Start Date :

January 1 2000

Trial Type :

INTERVENTIONAL

End Date :

October 1 2002

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00165100

Start Date

January 1 2000

End Date

October 1 2002

Last Update

December 28 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer | DecenTrialz